Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mech Behav Biomed Mater ; 136: 105461, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36195050

RESUMO

The adhesive interactions between molecular recognition units (such as specific peptides and antibodies) and antigens or other receptors on the surfaces of tumors are of great value in the design of targeted nanoparticles and drugs for the detection and treatment of specific cancers. In this paper, we present the results of a combined experimental and theoretical study of the adhesion between Luteinizing Hormone Releasing Hormone (LHRH)/Epherin type A2 (EphA2)-AFM coated tips and LHRH/EphA2 receptors that are overexpressed on the surfaces of human Triple Negative Breast Cancer (TNBC) tissues of different histological grades. Following a histochemical and immuno-histological study of human tissue extracts, the receptor overexpression, and their distributions are characterized using Immunohistochemistry (IHC), Immunofluorescence (IF), and a combination of fluorescence microscopy and confocal microscopy. The adhesion forces between LHRH or EphA2 and human TNBC breast tissues are measured using force microscopy techniques that account for the potential effects of capillary forces due to the presence of water vapor. The corresponding adhesion energies are also determined using adhesion theory. The pull off forces and adhesion energies associated with higher grades of TNBC are shown to be greater than those associated with normal/non-tumorigenic human breast tissues, which were studied as controls. The observed increase in adhesion forces and adhesion energies are also correlated with the increasing incidence of LHRH/EphA2 receptors at higher grades of TNBC. The implications of the results are discussed for the development of targeted nanostructures for the detection and treatment of TNBC.


Assuntos
Hormônio Liberador de Gonadotropina , Receptores LHRH , Neoplasias de Mama Triplo Negativas , Humanos , Linhagem Celular Tumoral , Hormônio Liberador de Gonadotropina/química , Nanopartículas , Receptores LHRH/química , Neoplasias de Mama Triplo Negativas/patologia
2.
Afr Health Sci ; 21(1): 54-59, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34394281

RESUMO

BACKGROUND: There has been a growing public health burden of childhood tumours in low and middle income countries (LMICs) as the trend in epidemiological transition continues to vary. OBJECTIVE: The objective of this report is to determine the spectrum of childhood tumours at a tertiary hospital in Nigeria. METHODS: A retrospective review of the histopathology register over the period January 2006 to December 2015. RESULTS: The total paediatric tumour cases was 248, including 143 (57.7%) females and 105 (42.3%) males, aged 0 - 12 years (mean 6.1 years ± 3.97 SD). The age group 2 - 5 year cohort had the highest prevalence of tumour. The predominant tumour based on tissue of origin was epithelial neoplasms 88 (35.5%), vascular neoplasms 56 (22.6%), neural neoplasm 42 (16.9%), mesenchymal neoplasm 37 (14.9%), germ cell neoplasm 13 (5.2%) and haematopoietic neoplasms 12 (4.8%). Majority of the tumours were benign, 148 (59.7%) and malignant 100 (40.3%). The most predominant benign tumour was haemangioma 33 (13.3%) and predominant malignant tumour was lymphoma 22 (8.9%). CONCLUSION: Benign tumours remain the commonest neoplasm of children in this hospital-based data. Development and implementation of a tumour registry would provide a more comprehensive information.


Assuntos
Hemangioma/patologia , Linfoma/patologia , Neoplasias/patologia , Distribuição por Idade , Criança , Pré-Escolar , Feminino , Hemangioma/epidemiologia , Humanos , Lactente , Recém-Nascido , Linfoma/epidemiologia , Masculino , Neoplasias/epidemiologia , Nigéria/epidemiologia , Prevalência , Sistema de Registros , Estudos Retrospectivos , Distribuição por Sexo , Centros de Atenção Terciária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...